Med-X is preparing for a possible NASDAQ listing (ticker: MXRX). But the real opportunity is now – before global validation changes everything.

In independent lab studies, Med-X’s all-natural pesticides have outperformed chemical brands in certain use cases, delivering powerful results without the toxic tradeoffs associated with traditional pest control.

Now, Med-X is pursuing a potential milestone that could redefine the industry: becoming the first botanical pesticide ever pre-qualified by the World Health Organization.

The global biopesticide market is projected to grow nearly 3x by 2030, expanding from $5.8 billion to $17.6 billion as governments move away from synthetic chemicals. A WHO pre-qualification would position Nature-Cide as a globally recognized solution for public health, agriculture, and mosquito-borne disease control – opening doors that most pesticide companies can’t access.

Nature-Cide’s plant-based formulation prioritizes safety while delivering industrial-grade performance, challenging long-held assumptions about what botanical solutions can achieve on a global scale.

NASDAQ Ticker: MXRX Reserved!
The Real Opportunity to Become a Shareholder Is Now!

Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, agricultural, and public-health sectors. Proudly manufactured in the USA, Nature-Cide reflects a commitment to scalable, sustainable innovation.

Already sold through eCommerce giants Amazon, Walmart, and Kroger, and expanding into 41 international markets, Med-X is positioning itself for its next major chapter.

Simpler. Safer. More Effective Pesticides.

Become a Med-X shareholder at $4 per share before their NASDAQ plans unfold.

---

Disclosures

This is a paid advertisement for Med-X’s Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com

Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO’s, CFO’s, COO’s and other insiders.

This message is a paid advertisement from Med-X, a third-party advertiser of InsiderTrades.com and MarketBeat. 

If you need help with your account, don’t hesitate to email our South Dakota based support team at contact@marketbeat.com.

If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.

Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Place #620, Sioux Falls, South Dakota 57103-7078. United States of America..